2-[[5-chloro-2-[[2-methyl-3-(morpholine-4-carbonyl)-1H-indol-6-yl]amino]pyrimidin-4-yl]amino]-N-methylbenzamide

C26H26ClN7O3 — CID 154640735

IUPAC2-[[5-chloro-2-[[2-methyl-3-(morpholine-4-carbonyl)-1H-indol-6-yl]amino]pyrimidin-4-yl]amino]-N-methylbenzamide
SMILESCNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(C(=O)N4CCOCC4)c(C)[nH]c3c2)ncc1Cl
InChIInChI=1S/C26H26ClN7O3/c1-15-22(25(36)34-9-11-37-12-10-34)17-8-7-16(13-21(17)30-15)31-26-29-14-19(27)23(33-26)32-20-6-4-3-5-18(20)24(35)28-2/h3-8,13-14,30H,9-12H2,1-2H3,(H,28,35)(H2,29,31,32,33)
InChIKeyTYUOWFNNDUWROL-UHFFFAOYSA-N
MW519.99 g/mol
LogP4.24
Rot. Bonds6

About 2-[[5-chloro-2-[[2-methyl-3-(morpholine-4-carbonyl)-1H-indol-6-yl]amino]pyrimidin-4-yl]amino]-N-methylbenzamide

2-[[5-chloro-2-[[2-methyl-3-(morpholine-4-carbonyl)-1H-indol-6-yl]amino]pyrimidin-4-yl]amino]-N-methylbenzamide (PubChem CID 154640735) has the molecular formula C26H26ClN7O3 and a molecular weight of 519.99 g/mol. Its IUPAC name is 2-[[5-chloro-2-[[2-methyl-3-(morpholine-4-carbonyl)-1H-indol-6-yl]amino]pyrimidin-4-yl]amino]-N-methylbenzamide.

Molecular Properties

Compound Name2-[[5-chloro-2-[[2-methyl-3-(morpholine-4-carbonyl)-1H-indol-6-yl]amino]pyrimidin-4-yl]amino]-N-methylbenzamide
PubChem CID154640735
Molecular FormulaC26H26ClN7O3
Molecular Weight519.99 g/mol
Exact Mass519.18
IUPAC Name2-[[5-chloro-2-[[2-methyl-3-(morpholine-4-carbonyl)-1H-indol-6-yl]amino]pyrimidin-4-yl]amino]-N-methylbenzamide
SMILESCNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(C(=O)N4CCOCC4)c(C)[nH]c3c2)ncc1Cl
InChIInChI=1S/C26H26ClN7O3/c1-15-22(25(36)34-9-11-37-12-10-34)17-8-7-16(13-21(17)30-15)31-26-29-14-19(27)23(33-26)32-20-6-4-3-5-18(20)24(35)28-2/h3-8,13-14,30H,9-12H2,1-2H3,(H,28,35)(H2,29,31,32,33)
InChIKeyTYUOWFNNDUWROL-UHFFFAOYSA-N
XLogP4.24
TPSA124.27 Ų
H-Bond Donors4
H-Bond Acceptors7
Rotatable Bonds6
Heavy Atoms37
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500519.99
LogP ≤ 54.24
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 107

Analyze 2-[[5-chloro-2-[[2-methyl-3-(morpholine-4-carbonyl)-1H-indol-6-yl]amino]pyrimidin-4-yl]amino]-N-methylbenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[[5-chloro-2-[[2-methyl-3-(morpholine-4-carbonyl)-1H-indol-6-yl]amino]pyrimidin-4-yl]amino]-N-methylbenzamide?
The IUPAC name of 2-[[5-chloro-2-[[2-methyl-3-(morpholine-4-carbonyl)-1H-indol-6-yl]amino]pyrimidin-4-yl]amino]-N-methylbenzamide (CID 154640735) is 2-[[5-chloro-2-[[2-methyl-3-(morpholine-4-carbonyl)-1H-indol-6-yl]amino]pyrimidin-4-yl]amino]-N-methylbenzamide.
What is the SMILES notation for 2-[[5-chloro-2-[[2-methyl-3-(morpholine-4-carbonyl)-1H-indol-6-yl]amino]pyrimidin-4-yl]amino]-N-methylbenzamide?
The canonical SMILES for 2-[[5-chloro-2-[[2-methyl-3-(morpholine-4-carbonyl)-1H-indol-6-yl]amino]pyrimidin-4-yl]amino]-N-methylbenzamide is CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(C(=O)N4CCOCC4)c(C)[nH]c3c2)ncc1Cl.
What is the InChIKey of 2-[[5-chloro-2-[[2-methyl-3-(morpholine-4-carbonyl)-1H-indol-6-yl]amino]pyrimidin-4-yl]amino]-N-methylbenzamide?
The InChIKey is TYUOWFNNDUWROL-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H26ClN7O3/c1-15-22(25(36)34-9-11-37-12-10-34)17-8-7-16(13-21(17)30-15)31-26-29-14-19(27)23(33-26)32-20-6-4-3-5-18(20)24(35)28-2/h3-8,13-14,30H,9-12H2,1-2H3,(H,28,35)(H2,29,31,32,33).
What are the key properties of 2-[[5-chloro-2-[[2-methyl-3-(morpholine-4-carbonyl)-1H-indol-6-yl]amino]pyrimidin-4-yl]amino]-N-methylbenzamide?
2-[[5-chloro-2-[[2-methyl-3-(morpholine-4-carbonyl)-1H-indol-6-yl]amino]pyrimidin-4-yl]amino]-N-methylbenzamide has a molecular weight of 519.99 g/mol, XLogP of 4.24, 6 rotatable bonds, 4 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[5-chloro-2-[[2-methyl-3-(morpholine-4-carbonyl)-1H-indol-6-yl]amino]pyrimidin-4-yl]amino]-N-methylbenzamide is sourced from PubChem (CID 154640735), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).